Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSX/BCT stock hub

TSX/BCT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/BCTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

41.5M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/BCT

In the news

Latest news · TSX/BCT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-179.2

P25 -121.5P50 -40.9P75 0.5

ROIC-114.9

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/BCT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

USD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	16
Employees Change	10%
Employees Change Percent	166.7
Enterprise value	CAD 30,650
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA10778Y3023
Last refreshed	2026-05-10
Market cap	CAD 41.5M
Price	CAD 5.73
Price currency	CAD
Sector	Healthcare
Sic	2836
Symbol	tsx/BCT
Website	https://briacell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-96.76%
EV Earnings	-0x
P/B ratio	1.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -40.2M
Net Income Growth Years	0%
Profit Per Employee	CAD -2.5M
ROA	-89.44
Roa5y	-65.05
ROCE	-101.1
ROE	-179.2
ROIC	-114.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-51.85%
Cagr1y	-87.42%
Cagr3y	-84.02%
Cagr5y	-60.56%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 45.6M
Cash	CAD 40.6M
Current Assets	CAD 44M
Current Liabilities	CAD 4.4M
Equity	CAD 41M
Interest Coverage	-831.2
Liabilities	CAD 4.6M
Long Term Assets	CAD 1.6M
Long Term Liabilities	CAD 230,736
Net Cash	CAD 40.6M
Net Cash By Market Cap	CAD 97.63
Net Cash Growth	496.44%
Net Debt Equity	CAD -0.99
Tangible Book Value	CAD 41.7M
Tangible Book Value Per Share	CAD 5.75
WACC	13.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.1
Net Working Capital	CAD -1.2M
Quick ratio	9.39
Working Capital	CAD 39.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-784.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.93%
1Y total return	-87.41%
200-day SMA	10.1
3Y total return	-99.59%
50-day SMA	5.68
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.04%
All Time High	21,150.2
All Time High Change	-99.97%
All Time High Date	2016-03-29
All Time Low	4.95
All Time Low Change	15.76%
All Time Low Date	2026-02-24
ATR	0.26
Beta	1.63
Beta1y	0.89
Beta2y	1.38
Ch YTD	-41.53
High	5.76
High52	51.5
High52 Date	2025-05-20
High52ch	-88.87%
Low	5.56
Low52	4.95
Low52 Date	2026-03-09
Low52ch	15.76%
Ma50ch	0.88%
Price vs 200-day SMA	-43.25%
RSI	51.57
RSI Monthly	31.96
RSI Weekly	34.3
Sharpe ratio	-0.78x
Sortino ratio	-0.94
Total Return	-784.7%
Tr YTD	-41.53
Tr1m	-5.29%
Tr1w	1.06%
Tr3m	0.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -41.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,410,284%
Shares Insiders	2.52%
Shares Institutions	3.24%
Shares Out	7,250,487
Shares Qo Q	48.75%
Shares Yo Y	784.7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	15,753.1x
Bv Per Share	5.78
Ch10y	-99.93
Ch1m	-5.29
Ch1w	1.06
Ch1y	-87.41
Ch3m	0.53
Ch3y	-99.59
Ch5y	-99.05
Ch6m	-63.96
Change	2.32%
Change From Open	3.06
Close	5.6
Days Gap	-0.71
Depreciation Amortization	145,764.4
Dollar Volume	22,008.9
Earnings Date	2026-06-05
EBIT	CAD -41.7M
EBITDA	CAD -41.5M
EPS	CAD -27.1
F Score	1
Financing CF	76,156,748
Fiscal Year End	July
Investing CF	-391,361
Is Primary Listing	1
Last Earnings Date	2025-12-12
Last Report Date	2026-01-31
Last Split Date	2025-08-25
Last Split Type	Reverse
Ma150	9.65
Ma150ch	-40.6%
Ma20	5.66
Ma20ch	1.18%
Net CF	33,761,010
Next Earnings Date	2026-06-05
Open	5.56
Position In Range	85
Ppne	343,322.3
Price Date	2026-05-08
Ptbv Ratio	1
Relative Volume	0.25x
Share Based Comp	1,092,394
Tr6m	-63.96%
Volume	3,841

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/BCT pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/BCT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/BCT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.2%

Share of float held by funds and institutions

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+784.7%

Negative means the company is buying back shares.

Technical

TSX/BCT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.6

Neutral momentum band

Price vs 200-day MA

-43.3%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

-0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/BCT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/BCT stock rating?

tsx/BCT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/BCT analysis?

The full report lives at /stocks/tsx/BCT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/BCT?

The latest report frames tsx/BCT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/BCT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.